Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: France Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20032
20042
20054
20063
20075
20086
20096
20103
20119
201210
20138
20147
20157
20165
20176
20185
20199
20206
202111
202212
20237
20246
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Recruiting28
Active, not recruiting25
Terminated22
Unknown status11
Not yet recruiting3
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche13
Janssen Research & Development, LLC11
Gilead Sciences10
European Organisation for Research and Treatment of Cancer - EORTC7
AbbVie6
AstraZeneca6
BeOne Medicines6
French Innovative Leukemia Organisation6
Institut Paoli-Calmettes6
Loxo Oncology, Inc.6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell165
Lymphoma, Non-Hodgkin47
Lymphoma, Follicular31
Lymphoma, Mantle-Cell30
Lymphoma, Large B-Cell, Diffuse28
Lymphoma, B-Cell, Marginal Zone27
Leukemia23
Recurrence22
Waldenstrom Macroglobulinemia20
Lymphoma18

Trials

Showing 76 to 100 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.